Lotus IVF is at the forefront of innovation in assisted reproductive technology, and we're thrilled to introduce Non-Invasive Preimplantation Genetic Testing (PGT) as part of our comprehensive suite of services. This groundbreaking advancement empowers prospective parents to screen embryos for genetic abnormalities with unparalleled accuracy and safety, all without the need for invasive procedures like embryo biopsy. Our Non-Invasive PGT service sets a new standard in fertility care, providing a smoother and more efficient path to parenthood for individuals and couples seeking to start or expand their families.
Non-Invasive PGT represents a significant leap forward in the field of reproductive medicine. This cutting-edge technology allows us to screen embryos for genetic abnormalities without subjecting them to invasive procedures, such as embryo biopsy. By harnessing advanced genetic screening techniques, Non-Invasive PGT offers prospective parents a safer, more efficient, and more informative approach to embryo selection.
At Lotus IVF, we understand the importance of providing cutting-edge solutions that prioritize the well-being of our patients and their future children. Non-Invasive PGT represents the pinnacle of genetic screening technology, offering a host of benefits over traditional methods:
Safety
Non-Invasive PGT eliminates the need for embryo biopsy, minimizing the risk of harm to the embryo and increasing the chances of successful implantation.
Accuracy
Leveraging advanced genetic screening techniques, Non-Invasive PGT delivers precise and reliable insights into embryo health and genetic makeup, empowering prospective parents with invaluable information.
Efficiency
With Non-Invasive PGT, we streamline the embryo screening process, reducing turnaround times and enabling faster decision-making, ultimately enhancing the overall IVF experience for our patients